This trial will test a new treatment for chronic ulcers of the lower legs and feet to see if it is safe and effective.
2 Primary · 0 Secondary · Reporting Duration: All adverse events (AEs) and serious adverse events (SAEs) will be recorded from the time of signing of the informed consent form through Week 64.
81 Total Participants · 2 Treatment Groups
Primary Treatment: PalinGen Flow Amniotic Tissue Allograft · No Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: